Amlot PL - Search Results

1

A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation.

Rees L, Tizard EJ, Morgan AJ, Cubitt WD, Finerty S, Oyewole-Eletu TA, Owen K, Royed C, Stevens SJ, Shroff RC, Tanday MK, Wilson AD, Middeldorp JM, Amlot PL, Steven NM. Rees L, et al. Among authors: amlot pl. Transplantation. 2009 Oct 27;88(8):1025-9. doi: 10.1097/TP.0b013e3181b9d918. Transplantation. 2009. PMID: 19855249 Clinical Trial.

2

Growth hormone and markers of immune function in children with renal transplants.

Maxwell H, Amlot P, Rees L. Maxwell H, et al. Pediatr Nephrol. 2000 Jun;14(6):473-5. doi: 10.1007/s004670050795. Pediatr Nephrol. 2000. PMID: 10872186 Clinical Trial.

3

A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease.

Guppy AE, Rawlings E, Madrigal JA, Amlot PL, Barber LD. Guppy AE, et al. Among authors: amlot pl. Transplantation. 2007 Dec 15;84(11):1534-9. doi: 10.1097/01.tp.0000290232.65830.e7. Transplantation. 2007. PMID: 18091531

4

Disappearance of an Epstein-Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression.

Rees L, Thomas A, Amlot PL. Rees L, et al. Among authors: amlot pl. Lancet. 1998 Sep 5;352(9130):789. doi: 10.1016/S0140-6736(05)60684-8. Lancet. 1998. PMID: 9737292 No abstract available.

5

What delay should there be between primary infectious mononucleosis and renal transplantation?

Kerecuk L, Amlot P, Riad H, Webb NJ. Kerecuk L, et al. Pediatr Transplant. 2006 Dec;10(8):970-3. doi: 10.1111/j.1399-3046.2006.00535.x. Pediatr Transplant. 2006. PMID: 17096769

6

Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals.

Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH. Thomas JA, et al. Transplantation. 1990 May;49(5):944-53. doi: 10.1097/00007890-199005000-00022. Transplantation. 1990. PMID: 2159663

7

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells.

Haque T, Taylor C, Wilkie GM, Murad P, Amlot PL, Beath S, McKiernan PJ, Crawford DH. Haque T, et al. Among authors: amlot pl. Transplantation. 2001 Oct 27;72(8):1399-402. doi: 10.1097/00007890-200110270-00012. Transplantation. 2001. PMID: 11685111

8

Minimal-change glomerular nephritis. Normal kidneys in an abnormal environment?

Ali AA, Wilson E, Moorhead JF, Amlot P, Abdulla A, Fernando ON, Dorman A, Sweny P. Ali AA, et al. Transplantation. 1994 Oct 15;58(7):849-52. Transplantation. 1994. PMID: 7940721 No abstract available.

9

Lack of specialized antigen-presenting cells (IDCs) in donor heart, kidney, liver, and lung at transplantation.

Amlot PL, Taylor P, Rose M, Sweny P, Janossy G, Yacoub M. Amlot PL, et al. Transplant Proc. 1989 Feb;21(1 Pt 1):169-70. Transplant Proc. 1989. PMID: 2495600 No abstract available.

10

Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation.

Amlot PL, Rawlings E, Fernando ON, Griffin PJ, Heinrich G, Schreier MH, Castaigne JP, Moore R, Sweny P. Amlot PL, et al. Transplantation. 1995 Oct 15;60(7):748-56. doi: 10.1097/00007890-199510150-00023. Transplantation. 1995. PMID: 7570988 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters